Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Research Report 2020

Publisher Name :
Date: 01-Jan-2020
No. of pages: 93
Inquire Before Buying

23-Valent Pneumococcal Polysaccharide Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria. 23-Valent Pneumococcal Polysaccharide Vaccine contains 23 of the most common types of pneumococcal bacteria.

23-Valent Pneumococcal Polysaccharide Vaccine is for use only in adults and children who are at least 2 years old. For children younger than 2 years old, another vaccine called Prevnar (pneumococcal conjugate vaccine [PCV] 7-valent) is used, usually given between the ages of 2 months and 15 months.

North America is the largest supplier and consumption market of 23-Valent Pneumococcal Polysaccharide Vaccine, with a production market share nearly 70% and sales market share nearly 28% in 2015. Because Sanofipasteur, a competitor from Europe, transferred its vaccine type gradually, the production market share of North America in the world has enjoyed a dramatic increase.

Market Analysis and Insights: Global 23-Valent Pneumococcal Polysaccharide Vaccine Market

The global 23-Valent Pneumococcal Polysaccharide Vaccine market is valued at 2058.1 million US$ in 2020 is expected to reach 5330.9 million US$ by the end of 2026, growing at a CAGR of 14.4% during 2021-2026.

Global 23-Valent Pneumococcal Polysaccharide Vaccine Market: Drivers and Restrains

The research report has incorporated the analysis of different factors that augment the market's growth. It constitutes trends, restraints, and drivers that transform the market in either a positive or negative manner. This section also provides the scope of different segments and applications that can potentially influence the market in the future. The detailed information is based on current trends and historic milestones. This section also provides an analysis of the volume of production about the global market and also about each type from 2015 to 2026. This section mentions the volume of production by region from 2015 to 2026. Pricing analysis is included in the report according to each type from the year 2015 to 2026, manufacturer from 2015 to 2020, region from 2015 to 2020, and global price from 2015 to 2026.

A thorough evaluation of the restrains included in the report portrays the contrast to drivers and gives room for strategic planning. Factors that overshadow the market growth are pivotal as they can be understood to devise different bends for getting hold of the lucrative opportunities that are present in the ever-growing market. Additionally, insights into market expert's opinions have been taken to understand the market better.

Market Segment Analysis

The research report includes specific segments by Type and by Application. Each type provides information about the production during the forecast period of 2015 to 2026. Application segment also provides consumption during the forecast period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

- Single Dose Vial

- Pre-filled Syringe

Segment by Application

- For Children (2-10)

- For Person (10-64)

- For The Old (=65)

Global 23-Valent Pneumococcal Polysaccharide Vaccine Market: Regional Analysis

The report offers in-depth assessment of the growth and other aspects of the 23-Valent Pneumococcal Polysaccharide Vaccine market in important regions, including the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, Taiwan, Southeast Asia, Mexico, and Brazil, etc. Key regions covered in the report are North America, Europe, Asia-Pacific and Latin America.

The report has been curated after observing and studying various factors that determine regional growth such as economic, environmental, social, technological, and political status of the particular region. Analysts have studied the data of revenue, production, and manufacturers of each region. This section analyses region-wise revenue and volume for the forecast period of 2015 to 2026. These analyses will help the reader to understand the potential worth of investment in a particular region.

Global 23-Valent Pneumococcal Polysaccharide Vaccine Market: Competitive Landscape

This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and production by manufacturers during the forecast period of 2015 to 2019.

The major players in the market include MSD, Sanofipasteur, CDIBP, etc.

Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Research Report 2020

Table of Contents
1 23-Valent Pneumococcal Polysaccharide Vaccine Market Overview
1.1 Product Overview and Scope of 23-Valent Pneumococcal Polysaccharide Vaccine
1.2 23-Valent Pneumococcal Polysaccharide Vaccine Segment by Type
1.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Production Growth Rate Comparison by Type 2020 VS 2026
1.2.2 Single Dose Vial
1.2.3 Pre-filled Syringe
1.3 23-Valent Pneumococcal Polysaccharide Vaccine Segment by Application
1.3.1 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Comparison by Application: 2020 VS 2026
1.3.2 For Children (2-10)
1.3.3 For Person (10-64)
1.3.4 For The Old (=65)
1.4 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market by Region
1.4.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Estimates and Forecasts by Region: 2020 VS 2026
1.4.2 North America Estimates and Forecasts (2015-2026)
1.4.3 Europe Estimates and Forecasts (2015-2026)
1.4.4 China Estimates and Forecasts (2015-2026)
1.4.5 Japan Estimates and Forecasts (2015-2026)
1.5 Global 23-Valent Pneumococcal Polysaccharide Vaccine Growth Prospects
1.5.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Estimates and Forecasts (2015-2026)
1.5.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Production Capacity Estimates and Forecasts (2015-2026)
1.5.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Production Estimates and Forecasts (2015-2026)
2 Market Competition by Manufacturers
2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Production Capacity Market Share by Manufacturers (2015-2020)
2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Manufacturers (2015-2020)
2.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.4 Global 23-Valent Pneumococcal Polysaccharide Vaccine Average Price by Manufacturers (2015-2020)
2.5 Manufacturers 23-Valent Pneumococcal Polysaccharide Vaccine Production Sites, Area Served, Product Types
2.6 23-Valent Pneumococcal Polysaccharide Vaccine Market Competitive Situation and Trends
2.6.1 23-Valent Pneumococcal Polysaccharide Vaccine Market Concentration Rate
2.6.2 Global Top 3 and Top 5 Players Market Share by Revenue
2.6.3 Mergers & Acquisitions, Expansion
3 Production Capacity by Region
3.1 Global Production Capacity of 23-Valent Pneumococcal Polysaccharide Vaccine Market Share by Regions (2015-2020)
3.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Regions (2015-2020)
3.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 North America 23-Valent Pneumococcal Polysaccharide Vaccine Production
3.4.1 North America 23-Valent Pneumococcal Polysaccharide Vaccine Production Growth Rate (2015-2020)
3.4.2 North America 23-Valent Pneumococcal Polysaccharide Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Production
3.5.1 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Production Growth Rate (2015-2020)
3.5.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 China 23-Valent Pneumococcal Polysaccharide Vaccine Production
3.6.1 China 23-Valent Pneumococcal Polysaccharide Vaccine Production Growth Rate (2015-2020)
3.6.2 China 23-Valent Pneumococcal Polysaccharide Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 Japan 23-Valent Pneumococcal Polysaccharide Vaccine Production
3.7.1 Japan 23-Valent Pneumococcal Polysaccharide Vaccine Production Growth Rate (2015-2020)
3.7.2 Japan 23-Valent Pneumococcal Polysaccharide Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
4 Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Regions
4.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Regions
4.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Region
4.1.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Region
4.2 North America
4.2.1 North America 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Countries
4.2.2 U.S.
4.2.3 Canada
4.3 Europe
4.3.1 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Countries
4.3.2 Germany
4.3.3 France
4.3.4 U.K.
4.3.5 Italy
4.3.6 Russia
4.4 Asia Pacific
4.4.1 Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Region
4.4.2 China
4.4.3 Japan
4.4.4 South Korea
4.4.5 Taiwan
4.4.6 Southeast Asia
4.4.7 India
4.4.8 Australia
4.5 Latin America
4.5.1 Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Countries
4.5.2 Mexico
4.5.3 Brazil
5 Production, Revenue, Price Trend by Type
5.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Production Market Share by Type (2015-2020)
5.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2015-2020)
5.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Price by Type (2015-2020)
5.4 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
6 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Analysis by Application
6.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Application (2015-2020)
6.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth Rate by Application (2015-2020)
7 Company Profiles and Key Figures in 23-Valent Pneumococcal Polysaccharide Vaccine Business
7.1 MSD
7.1.1 MSD 23-Valent Pneumococcal Polysaccharide Vaccine Production Sites and Area Served
7.1.2 23-Valent Pneumococcal Polysaccharide Vaccine Product Introduction, Application and Specification
7.1.3 MSD 23-Valent Pneumococcal Polysaccharide Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.1.4 Main Business and Markets Served
7.2 Sanofipasteur
7.2.1 Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Production Sites and Area Served
7.2.2 23-Valent Pneumococcal Polysaccharide Vaccine Product Introduction, Application and Specification
7.2.3 Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.2.4 Main Business and Markets Served
7.3 CDIBP
7.3.1 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Production Sites and Area Served
7.3.2 23-Valent Pneumococcal Polysaccharide Vaccine Product Introduction, Application and Specification
7.3.3 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.3.4 Main Business and Markets Served
8 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturing Cost Analysis
8.1 23-Valent Pneumococcal Polysaccharide Vaccine Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Raw Materials Price Trend
8.1.3 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of 23-Valent Pneumococcal Polysaccharide Vaccine
8.4 23-Valent Pneumococcal Polysaccharide Vaccine Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 23-Valent Pneumococcal Polysaccharide Vaccine Distributors List
9.3 23-Valent Pneumococcal Polysaccharide Vaccine Customers
10 Market Dynamics
10.1 Market Trends
10.2 Opportunities and Drivers
10.3 Challenges
10.4 Porter's Five Forces Analysis
11 Production and Supply Forecast
11.1 Global Forecasted Production of 23-Valent Pneumococcal Polysaccharide Vaccine (2021-2026)
11.2 Global Forecasted Revenue of 23-Valent Pneumococcal Polysaccharide Vaccine (2021-2026)
11.3 Global Forecasted Price of 23-Valent Pneumococcal Polysaccharide Vaccine (2021-2026)
11.4 Global 23-Valent Pneumococcal Polysaccharide Vaccine Production Forecast by Regions (2021-2026)
11.4.1 North America 23-Valent Pneumococcal Polysaccharide Vaccine Production, Revenue Forecast (2021-2026)
11.4.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Production, Revenue Forecast (2021-2026)
11.4.3 China 23-Valent Pneumococcal Polysaccharide Vaccine Production, Revenue Forecast (2021-2026)
11.4.4 Japan 23-Valent Pneumococcal Polysaccharide Vaccine Production, Revenue Forecast (2021-2026)
12 Consumption and Demand Fprecast
12.1 Global Forecasted and Consumption Demand Analysis of 23-Valent Pneumococcal Polysaccharide Vaccine
12.2 North America Forecasted Consumption of 23-Valent Pneumococcal Polysaccharide Vaccine by Country
12.3 Europe Market Forecasted Consumption of 23-Valent Pneumococcal Polysaccharide Vaccine by Country
12.4 Asia Pacific Market Forecasted Consumption of 23-Valent Pneumococcal Polysaccharide Vaccine by Regions
12.5 Latin America Forecasted Consumption of 23-Valent Pneumococcal Polysaccharide Vaccine
13 Forecast by Type and by Application (2021-2026)
13.1 Global Production, Revenue and Price Forecast by Type (2021-2026)
13.1.1 Global Forecasted Production of 23-Valent Pneumococcal Polysaccharide Vaccine by Type (2021-2026)
13.1.2 Global Forecasted Revenue of 23-Valent Pneumococcal Polysaccharide Vaccine by Type (2021-2026)
13.1.2 Global Forecasted Price of 23-Valent Pneumococcal Polysaccharide Vaccine by Type (2021-2026)
13.2 Global Forecasted Consumption of 23-Valent Pneumococcal Polysaccharide Vaccine by Application (2021-2026)
14 Reseach Finding and Conclusion
15 Methodology and Data Source
15.1 Methodology/Research Approach
15.1.1 Research Programs/Design
15.1.2 Market Size Estimation
15.1.3 Market Breakdown and Data Triangulation
15.2 Data Source
15.2.1 Secondary Sources
15.2.2 Primary Sources
15.3 Author List
15.4 Disclaimer
List of Tables
Table 1. Global 23-Valent Pneumococcal Polysaccharide Vaccine Production (K Dose) Growth Rate Comparison by Type (2015-2026)
Table 2. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Type (K Dose) (US$ Million) (2020 VS 2026)
Table 3. Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption (K Dose) Comparison by Application: 2020 VS 2026
Table 4. Global 23-Valent Pneumococcal Polysaccharide Vaccine Production (K Dose) by Manufacturers
Table 5. Global 23-Valent Pneumococcal Polysaccharide Vaccine Production (K Dose) by Manufacturers (2015-2020)
Table 6. Global 23-Valent Pneumococcal Polysaccharide Vaccine Production Share by Manufacturers (2015-2020)
Table 7. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Manufacturers (2015-2020)
Table 9. Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in 23-Valent Pneumococcal Polysaccharide Vaccine as of 2019)
Table 10. Global Market 23-Valent Pneumococcal Polysaccharide Vaccine Average Price (USD/Dose) of Key Manufacturers (2015-2020)
Table 11. Manufacturers 23-Valent Pneumococcal Polysaccharide Vaccine Production Sites and Area Served
Table 12. Manufacturers 23-Valent Pneumococcal Polysaccharide Vaccine Product Types
Table 13. Global 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14.Mergers & Acquisitions, Expansion
Table 15. Global 23-Valent Pneumococcal Polysaccharide Vaccine Capacity (K Dose) by Region (2015-2020)
Table 16. Global 23-Valent Pneumococcal Polysaccharide Vaccine Production (K Dose) by Region (2015-2020)
Table 17. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million US$) by Region (2015-2020)
Table 18. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region (2015-2020)
Table 19. Global 23-Valent Pneumococcal Polysaccharide Vaccine Production Capacity (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 20. North America 23-Valent Pneumococcal Polysaccharide Vaccine Production Capacity (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 21. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Production Capacity (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 22. China 23-Valent Pneumococcal Polysaccharide Vaccine Production Capacity (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 23. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Production Capacity (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 24. Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption (K Dose) Market by Region (2015-2020)
Table 25. Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Region (2015-2020)
Table 26. North America 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Countries (2015-2020) (K Dose)
Table 27. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Countries (2015-2020) (K Dose)
Table 28. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Countries (2015-2020) (K Dose)
Table 29. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Countries (2015-2020) (K Dose)
Table 30. Global 23-Valent Pneumococcal Polysaccharide Vaccine Production (K Dose) by Type (2015-2020)
Table 31. Global 23-Valent Pneumococcal Polysaccharide Vaccine Production Share by Type (2015-2020)
Table 32. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million US$) by Type (2015-2020)
Table 33. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Type (2015-2020)
Table 34. Global 23-Valent Pneumococcal Polysaccharide Vaccine Price (USD/Dose) by Type (2015-2020)
Table 35. Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption (K Dose) by Application (2015-2020)
Table 36. Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Application (2015-2020)
Table 37. Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth Rate by Application (2015-2020)
Table 38. MSD 23-Valent Pneumococcal Polysaccharide Vaccine Production Sites and Area Served
Table 39. MSD Production Sites and Area Served
Table 40. MSD 23-Valent Pneumococcal Polysaccharide Vaccine Production Capacity (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 41. MSD Main Business and Markets Served
Table 42. Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Production Sites and Area Served
Table 43. Sanofipasteur Production Sites and Area Served
Table 44. Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Production Capacity (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 45. Sanofipasteur Main Business and Markets Served
Table 46. CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Production Sites and Area Served
Table 47. CDIBP Production Sites and Area Served
Table 48. CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Production Capacity (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 49. CDIBP Main Business and Markets Served
Table 50. Production Base and Market Concentration Rate of Raw Material
Table 51. Key Suppliers of Raw Materials
Table 52. 23-Valent Pneumococcal Polysaccharide Vaccine Distributors List
Table 53. 23-Valent Pneumococcal Polysaccharide Vaccine Customers List
Table 54. Market Key Trends
Table 55. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 56. Key Challenges
Table 57. Global 23-Valent Pneumococcal Polysaccharide Vaccine Production (K Dose) Forecast by Region (2021-2026)
Table 58. North America 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast 2021-2026 (K Dose) by Country
Table 59. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast 2021-2026 (K Dose) by Country
Table 60. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast 2021-2026 (K Dose) by Regions
Table 61. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast 2021-2026 (K Dose) by Country
Table 62. Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption (K Dose) Forecast by Regions (2021-2026)
Table 63. Global 23-Valent Pneumococcal Polysaccharide Vaccine Production (K Dose) Forecast by Type (2021-2026)
Table 64. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million US$) Forecast by Type (2021-2026)
Table 65. Global 23-Valent Pneumococcal Polysaccharide Vaccine Price (USD/Dose) Forecast by Type (2021-2026)
Table 66. Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption (K Dose) Forecast by Application (2021-2026)
Table 67.Research Programs/Design for This Report
Table 68.Key Data Information from Secondary Sources
Table 69.Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of 23-Valent Pneumococcal Polysaccharide Vaccine
Figure 2. Global 23-Valent Pneumococcal Polysaccharide Vaccine Production Market Share by Type: 2020 VS 2026
Figure 3. Single Dose Vial Product Picture
Figure 4. Pre-filled Syringe Product Picture
Figure 5. Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Application: 2020 VS 2026
Figure 6. For Children (2-10)
Figure 7. For Person (10-64)
Figure 8. For The Old (=65)
Figure 9. North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million US$) and Growth Rate (2015-2026)
Figure 10. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million US$) and Growth Rate (2015-2026)
Figure 11. China 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million US$) and Growth Rate (2015-2026)
Figure 12. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million US$) and Growth Rate (2015-2026)
Figure 13. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million US$) (2015-2026)
Figure 14. Global 23-Valent Pneumococcal Polysaccharide Vaccine Production Capacity (K Dose) (2015-2026)
Figure 15. 23-Valent Pneumococcal Polysaccharide Vaccine Production Share by Manufacturers in 2019
Figure 16. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Manufacturers in 2019
Figure 17. 23-Valent Pneumococcal Polysaccharide Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 18. Global Market 23-Valent Pneumococcal Polysaccharide Vaccine Average Price (USD/Dose) of Key Manufacturers in 2019
Figure 19. The Global 5 and 10 Largest Players: Market Share by 23-Valent Pneumococcal Polysaccharide Vaccine Revenue in 2019
Figure 20. Global 23-Valent Pneumococcal Polysaccharide Vaccine Production Market Share by Region (2015-2020)
Figure 21. Global 23-Valent Pneumococcal Polysaccharide Vaccine Production Market Share by Region in 2019
Figure 22. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region (2015-2020)
Figure 23. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region in 2019
Figure 24. Global 23-Valent Pneumococcal Polysaccharide Vaccine Production (K Dose) Growth Rate (2015-2020)
Figure 25. North America 23-Valent Pneumococcal Polysaccharide Vaccine Production (K Dose) Growth Rate (2015-2020)
Figure 26. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Production (K Dose) Growth Rate (2015-2020)
Figure 27. China 23-Valent Pneumococcal Polysaccharide Vaccine Production (K Dose) Growth Rate (2015-2020)
Figure 28. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Production (K Dose) Growth Rate (2015-2020)
Figure 29. Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Region (2015-2020)
Figure 30. Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Region in 2019
Figure 31. North America 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth Rate (2015-2020) (K Dose)
Figure 32. North America 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Countries in 2019
Figure 33. Canada 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth Rate (2015-2020) (K Dose)
Figure 34. U.S. 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth Rate (2015-2020) (K Dose)
Figure 35. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth Rate (2015-2020) (K Dose)
Figure 36. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Countries in 2019
Figure 37. Germany America 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth Rate (2015-2020) (K Dose)
Figure 38. France 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth Rate (2015-2020) (K Dose)
Figure 39. U.K. 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth Rate (2015-2020) (K Dose)
Figure 40. Italy 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth Rate (2015-2020) (K Dose)
Figure 41. Russia 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth Rate (2015-2020) (K Dose)
Figure 42. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth Rate (2015-2020) (K Dose)
Figure 43. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Regions in 2019
Figure 44. China 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth Rate (2015-2020) (K Dose)
Figure 45. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth Rate (2015-2020) (K Dose)
Figure 46. South Korea 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth Rate (2015-2020) (K Dose)
Figure 47. Taiwan 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth Rate (2015-2020) (K Dose)
Figure 48. Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth Rate (2015-2020) (K Dose)
Figure 49. India 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth Rate (2015-2020) (K Dose)
Figure 50. Australia 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth Rate (2015-2020) (K Dose)
Figure 51. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth Rate (2015-2020) (K Dose)
Figure 52. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Countries in 2019
Figure 53. Mexico 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth Rate (2015-2020) (K Dose)
Figure 54. Brazil 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth Rate (2015-2020) (K Dose)
Figure 55. Production Market Share of 23-Valent Pneumococcal Polysaccharide Vaccine by Type (2015-2020)
Figure 56. Production Market Share of 23-Valent Pneumococcal Polysaccharide Vaccine by Type in 2019
Figure 57. Revenue Share of 23-Valent Pneumococcal Polysaccharide Vaccine by Type (2015-2020)
Figure 58. Revenue Market Share of 23-Valent Pneumococcal Polysaccharide Vaccine by Type in 2019
Figure 59. Global 23-Valent Pneumococcal Polysaccharide Vaccine Production Growth by Type (2015-2020) (K Dose)
Figure 60. Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Application (2015-2020)
Figure 61. Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Application in 2019
Figure 62. Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth Rate by Application (2015-2020)
Figure 63. Price Trend of Key Raw Materials
Figure 64. Manufacturing Cost Structure of 23-Valent Pneumococcal Polysaccharide Vaccine
Figure 65. Manufacturing Process Analysis of 23-Valent Pneumococcal Polysaccharide Vaccine
Figure 66. 23-Valent Pneumococcal Polysaccharide Vaccine Industrial Chain Analysis
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles
Figure 69. Porter's Five Forces Analysis
Figure 70. Global 23-Valent Pneumococcal Polysaccharide Vaccine Production Capacity (K Dose) and Growth Rate Forecast (2021-2026)
Figure 71. Global 23-Valent Pneumococcal Polysaccharide Vaccine Production (K Dose) and Growth Rate Forecast (2021-2026)
Figure 72. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 73. Global 23-Valent Pneumococcal Polysaccharide Vaccine Price and Trend Forecast (2021-2026)
Figure 74. Global 23-Valent Pneumococcal Polysaccharide Vaccine Production Market Share Forecast by Region (2021-2026)
Figure 75. North America 23-Valent Pneumococcal Polysaccharide Vaccine Production (K Dose) and Growth Rate Forecast (2021-2026)
Figure 76. North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 77. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Production (K Dose) and Growth Rate Forecast (2021-2026)
Figure 78. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 79. China 23-Valent Pneumococcal Polysaccharide Vaccine Production (K Dose) and Growth Rate Forecast (2021-2026)
Figure 80. China 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 81. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Production (K Dose) and Growth Rate Forecast (2021-2026)
Figure 82. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 83. Global Forecasted and Consumption Demand Analysis of 23-Valent Pneumococcal Polysaccharide Vaccine
Figure 84. North America 23-Valent Pneumococcal Polysaccharide Vaccine Consumption (K Dose) Growth Rate Forecast (2021-2026)
Figure 85. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Consumption (K Dose) Growth Rate Forecast (2021-2026)
Figure 86. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Consumption (K Dose) Growth Rate Forecast (2021-2026)
Figure 87. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Consumption (K Dose) Growth Rate Forecast (2021-2026)
Figure 88. Global 23-Valent Pneumococcal Polysaccharide Vaccine Production (K Dose) Forecast by Type (2021-2026)
Figure 89. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share Forecast by Type (2021-2026)
Figure 90. Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast by Application (2021-2026)
Figure 91. Bottom-up and Top-down Approaches for This Report
Figure 92. Data Triangulation
  • Global Avian Influenza Vaccines Market Research Report 2015-2025
    Published: 25-Feb-2020        Price: US 2120 Onwards        Pages: 104
    Summary Avian influenza refers to the disease caused by infection with avian (bird) influenza (flu) Type A viruses. These viruses occur naturally among wild aquatic birds worldwide and can infect domestic poultry and other bird and animal species. Avian flu viruses do not normally infect humans. However, sporadic human infections with avian flu viruses have occurred. The global Avian Influenza Vaccines market will reach xxx Million USD in 2020 with CAGR xx% 2020-202......
  • Global H1N1 Vaccines Market Analysis 2015-2019 and Forecast 2020-2025
    Published: 22-Feb-2020        Price: US 2980 Onwards        Pages: 94
    Snapshot The global H1N1 Vaccines market size is estimated at xxx million USD with a CAGR xx% from 2015-2019 and is expected to reach xxx Million USD in 2020 with a CAGR xx% from 2020 to 2025. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of H1N1 Vaccines by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile,......
  • Global Pneumococcal Polysaccharide Vaccine Market Research Report 2020
    Published: 20-Feb-2020        Price: US 2900 Onwards        Pages: 92
    This report focuses on Pneumococcal Polysaccharide Vaccine volume and value at global level, regional level and company level. From a global perspective, this report represents overall Pneumococcal Polysaccharide Vaccine market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan. At company level, this report focuses on the production capacity, ex-factory price, revenue and market sha......
  • Global Meningococcal Vaccines Market Analysis 2015-2019 and Forecast 2020-2025
    Published: 17-Feb-2020        Price: US 2980 Onwards        Pages: 85
    Snapshot The global Meningococcal Vaccines market size is estimated at xxx million USD with a CAGR xx% from 2015-2019 and is expected to reach xxx Million USD in 2020 with a CAGR xx% from 2020 to 2025. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Meningococcal Vaccines by product, region and application, in addition, this report introduces market competition situation among the vendors an......
  • Global Encephalitis Vaccination Market Growth (Status and Outlook) 2020-2025
    Published: 13-Feb-2020        Price: US 3660 Onwards        Pages: 117
    According to this study, over the next five years the Encephalitis Vaccination market will register a 5.8% CAGR in terms of revenue, the global market size will reach $ 1413.7 million by 2025, from $ 1127.9 million in 2019. In particular, this report presents the global revenue market share of key companies in Encephalitis Vaccination business, shared in Chapter 3. This report presents a comprehensive overview, market shares and growth opportunities of Encephalitis Vaccination mar......
  • Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Growth 2020-2025
    Published: 10-Feb-2020        Price: US 3660 Onwards        Pages: 139
    According to this study, over the next five years the 23-Valent Pneumococcal Polysaccharide Vaccine market will register a 14.9% CAGR in terms of revenue, the global market size will reach $ 3513.8 million by 2025, from $ 2013.3 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in 23-Valent Pneumococcal Polysaccharide Vaccine business, shared in Chapter 3. This report presents a comprehensive overview, market shares, ......
  • DPT Vaccine Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    Published: 09-Feb-2020        Price: US 3000 Onwards        Pages: 145
    DPT Vaccine Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global DPT Vaccine industry with a focus on the Chinese market. The report provides key statistics on the market status of the DPT Vaccine manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Overall, the report provides an in-depth insight of 2014-2024 global and Chinese DPT Vaccine market covering al......
  • Pneumococcal Polysaccharide Vaccine Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    Published: 09-Feb-2020        Price: US 3000 Onwards        Pages: 139
    Pneumococcal Polysaccharide Vaccine Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Pneumococcal Polysaccharide Vaccine industry with a focus on the Chinese market. The report provides key statistics on the market status of the Pneumococcal Polysaccharide Vaccine manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Overall, the report provides an in-dept......
  • Encephalitis Vaccine Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    Published: 09-Feb-2020        Price: US 3000 Onwards        Pages: 141
    Encephalitis Vaccine Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Encephalitis Vaccine industry with a focus on the Chinese market. The report provides key statistics on the market status of the Encephalitis Vaccine manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Overall, the report provides an in-depth insight of 2014-2024 global and Chinese Enc......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs